<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: This review focuses on recent literature on <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in youth with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> is associated with a variety of cardiometabolic problems leading to increased morbidity and mortality across the lifespan </plain></SENT>
<SENT sid="2" pm="."><plain>RECENT FINDINGS: Functional pancreatic Î²-cell changes play a role in the transition from <z:hpo ids='HP_0001513'>obesity</z:hpo> to <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> drives islet cell upregulation, manifested by elevated glucagon and c-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels, early in the transition to IGT </plain></SENT>
<SENT sid="4" pm="."><plain>Surrogate measurements of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and insulin secretion exist but their accuracy compared to clamp data is imperfect </plain></SENT>
<SENT sid="5" pm="."><plain>Recent large longitudinal studies provide detailed information on the progression from normoglycemia to T2DM and on the phenotype of T2DM youth </plain></SENT>
<SENT sid="6" pm="."><plain>Defining <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and T2DM remains a challenge in youth </plain></SENT>
<SENT sid="7" pm="."><plain>Lifestyle interventions do not appear as effective in children as in adults </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="6801">Metformin</z:chebi> remains the only oral <z:chebi fb="0" ids="35526">hypoglycemic agent</z:chebi> approved for T2DM in youth </plain></SENT>
<SENT sid="9" pm="."><plain>SUMMARY: New insights exist regarding the conversion from <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> to T2DM, measurement of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and phenotypes of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> youth, but more information is needed </plain></SENT>
<SENT sid="10" pm="."><plain>Surrogate measurements of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, additional treatment options for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and individualization of treatment options for T2DM adolescents in particular require further investigation </plain></SENT>
</text></document>